載入...
Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial
Background. Diuresis is a major therapy for the reduction of congestive symptoms in acute decompensated heart failure (ADHF) patients. We previously reported the efficacy and safety of tolvaptan compared to carperitide in hospitalized patients with ADHF. There were some reports of cardio- and renal-...
Na minha lista:
| 發表在: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Publishing Corporation
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243738/ https://ncbi.nlm.nih.gov/pubmed/25436213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/704289 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|